companydata.dkcompanydata.dk

PHARMADVICE ApS: Financial statements 2025

CVR: 26527651

Source: annual report 2025, Danish Business Authority

01/01/202531/12/2025

PHARMADVICE ApS (CVR 26527651) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 6,375,693 and a net result of DKK 503,512 compared with DKK 658,935 the year before. That is a decrease of 5.1% compared with the year before. Equity in the 2025 report amounted to DKK 1,402,268. The solvency ratio was 66.3%. The company had 6 employees in the financial year.

Gross Profit
DKK 6,375,693
Profit/Loss
DKK 503,512
Equity
DKK 1,402,268
Total Assets
DKK 2,114,476
Employees
6

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-6.4 mio.504 t.1.4 mio.6
2024-6.7 mio.659 t.1.5 mio.7
2023-5.9 mio.609 t.1.4 mio.6
2022-5.3 mio.717 t.1.5 mio.6
2021-3.9 mio.276 t.839 t.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMADVICE ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

PHARMADVICE ApS: The 2024 annual report is outMay 20, 2025

PHARMADVICE ApS has published its annual report for 2024. Gross profit came to DKK 6,719,182, and the net result was DKK 658,935.

About PHARMADVICE ApS

PHARMADVICE ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2002. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Susanne Ølsgaard Felumb. The company is owned by Felumb Holding ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 6,375,693 and a net result of DKK 503,512 compared with DKK 658,935 the year before. Equity in the 2025 report amounted to DKK 1,402,268.

Source: annual report 2025, Danish Business Authority